Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 249

1.

[Next generation zebrafish-based drug discovery and precision medicine].

Tanaka T, Koiwa J.

Nihon Yakurigaku Zasshi. 2019;154(2):78-83. doi: 10.1254/fpj.154.78. Review. Japanese.

PMID:
31406047
2.

Aging-associated microstructural deterioration of vertebra in zebrafish.

Monma Y, Shimada Y, Nakayama H, Zang L, Nishimura N, Tanaka T.

Bone Rep. 2019 Jul 17;11:100215. doi: 10.1016/j.bonr.2019.100215. eCollection 2019 Dec.

3.

Targeting Interleukin-6 Signaling in Clinic.

Kang S, Tanaka T, Narazaki M, Kishimoto T.

Immunity. 2019 Apr 16;50(4):1007-1023. doi: 10.1016/j.immuni.2019.03.026. Review.

PMID:
30995492
4.

Zebrafish yolk sac microinjection of thalidomide for assessment of developmental toxicology.

Mikami I, Takahashi Y, Koiwa J, Okamura M, Tanaka T.

Congenit Anom (Kyoto). 2019 Apr 1. doi: 10.1111/cga.12335. [Epub ahead of print]

PMID:
30932217
5.

Toxicological Evaluation of SiO₂ Nanoparticles by Zebrafish Embryo Toxicity Test.

Vranic S, Shimada Y, Ichihara S, Kimata M, Wu W, Tanaka T, Boland S, Tran L, Ichihara G.

Int J Mol Sci. 2019 Feb 18;20(4). pii: E882. doi: 10.3390/ijms20040882.

6.

Potential Beneficial Effects of Wine Flavonoids on Allergic Diseases.

Tanaka T, Iuchi A, Harada H, Hashimoto S.

Diseases. 2019 Jan 15;7(1). pii: E8. doi: 10.3390/diseases7010008. Review.

7.

Increased susceptibility to oxidative stress-induced toxicological evaluation by genetically modified nrf2a-deficient zebrafish.

Yamashita A, Deguchi J, Honda Y, Yamada T, Miyawaki I, Nishimura Y, Tanaka T.

J Pharmacol Toxicol Methods. 2019 Mar - Apr;96:34-45. doi: 10.1016/j.vascn.2018.12.006. Epub 2018 Dec 27.

PMID:
30594530
8.

IL-6 blockade for myocardial infarction.

Iuchi A, Harada H, Tanaka T.

Int J Cardiol. 2018 Nov 15;271:19-20. doi: 10.1016/j.ijcard.2018.06.068. Epub 2018 Jun 21. No abstract available.

PMID:
30482454
9.

The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis.

Mertz P, Belot A, Cervera R, Chuah TY, Dagna L, Damian L, Danda D, D'cruz D, Espinosa G, Frances C, Jayne D, Ooi KK, Kucharz EJ, Lebovics R, Marie I, Moulis G, Peng S, Sharma A, Suzuki N, Tanaka T, Van Vollenhoven R, Sibilia J, Gottenberg JE, Chasset F, Arnaud L.

Joint Bone Spine. 2019 May;86(3):363-368. doi: 10.1016/j.jbspin.2018.11.001. Epub 2018 Nov 15.

PMID:
30448476
10.

The clinical importance of a cytokine network in the acute phase of sepsis.

Matsumoto H, Ogura H, Shimizu K, Ikeda M, Hirose T, Matsuura H, Kang S, Takahashi K, Tanaka T, Shimazu T.

Sci Rep. 2018 Sep 18;8(1):13995. doi: 10.1038/s41598-018-32275-8.

11.

1-Kestose, the Smallest Fructooligosaccharide Component, Which Efficiently Stimulates Faecalibacterium prausnitzii as Well as Bifidobacteria in Humans.

Tochio T, Kadota Y, Tanaka T, Koga Y.

Foods. 2018 Sep 1;7(9). pii: E140. doi: 10.3390/foods7090140. Review.

12.

Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors.

Ito M, Tanaka T, Toita A, Uchiyama N, Kokubo H, Morishita N, Klein MG, Zou H, Murakami M, Kondo M, Sameshima T, Araki S, Endo S, Kawamoto T, Morin GB, Aparicio SA, Nakanishi A, Maezaki H, Imaeda Y.

J Med Chem. 2018 Sep 13;61(17):7710-7728. doi: 10.1021/acs.jmedchem.8b00683. Epub 2018 Aug 20.

PMID:
30067358
13.

Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).

Kaneko Y, Kato M, Tanaka Y, Inoo M, Kobayashi-Haraoka H, Amano K, Miyata M, Murakawa Y, Yasuoka H, Hirata S, Tanaka E, Miyasaka N, Yamanaka H, Yamamoto K, Takeuchi T; SURPRISE study group.

Ann Rheum Dis. 2018 Sep;77(9):1268-1275. doi: 10.1136/annrheumdis-2018-213416. Epub 2018 May 31.

14.

IL-6: A New Era for the Treatment of Autoimmune Inflammatory Diseases.

Kishimoto T, Kang S, Tanaka T.

In: Nakao K, Minato N, Uemoto S, editors. Innovative Medicine: Basic Research and Development [Internet]. Tokyo: Springer; 2015.

15.

Effect of nagilactone E on cell morphology and glucan biosynthesis in budding yeast Saccharomyces cerevisiae.

Hayashi K, Yamaguchi Y, Ogita A, Tanaka T, Kubo I, Fujita KI.

Fitoterapia. 2018 Jul;128:112-117. doi: 10.1016/j.fitote.2018.05.003. Epub 2018 May 14.

PMID:
29772300
16.

Search for a Novel Allergen in Hen's Egg Allergy Using an IgE Immunoblotting Assay.

Sogawa K, Takahashi Y, Shibata Y, Satoh M, Kodera Y, Nomura F, Tanaka T, Sato H, Yamaide F, Nakano T, Iwahashi K, Sugita-Konishi Y, Shimada A, Shimojo N.

Int Arch Allergy Immunol. 2018;176(3-4):189-197. doi: 10.1159/000488144. Epub 2018 Apr 18.

PMID:
29669337
17.

Clinical Importance of a Cytokine Network in Major Burns.

Matsuura H, Matsumoto H, Osuka A, Ogura H, Shimizu K, Kang S, Tanaka T, Ueyama M, Shimazu T.

Shock. 2019 Feb;51(2):185-193. doi: 10.1097/SHK.0000000000001152.

PMID:
29621119
18.

EGF receptor kinase suppresses ciliogenesis through activation of USP8 deubiquitinase.

Kasahara K, Aoki H, Kiyono T, Wang S, Kagiwada H, Yuge M, Tanaka T, Nishimura Y, Mizoguchi A, Goshima N, Inagaki M.

Nat Commun. 2018 Feb 22;9(1):758. doi: 10.1038/s41467-018-03117-y.

19.

Clonal evolution and antigen recognition of anti-nuclear antibodies in acute systemic lupus erythematosus.

Sakakibara S, Arimori T, Yamashita K, Jinzai H, Motooka D, Nakamura S, Li S, Takeda K, Katayama J, El Hussien MA, Narazaki M, Tanaka T, Standley DM, Takagi J, Kikutani H.

Sci Rep. 2017 Nov 27;7(1):16428. doi: 10.1038/s41598-017-16681-y.

20.

Chemokines protect vascular smooth muscle cells from cell death induced by cyclic mechanical stretch.

Zhao J, Nishimura Y, Kimura A, Ozawa K, Kondo T, Tanaka T, Yoshizumi M.

Sci Rep. 2017 Nov 23;7(1):16128. doi: 10.1038/s41598-017-15867-8.

Supplemental Content

Loading ...
Support Center